This year (2015) marks the tenth anniversary for the Terrapinn World Stem Cells & Regenerative Medicine Congress, but the question in my wind is how far has this industry travelled in those years.
Returning to this conference for the third year and now with more than ten years involvement in the sector I hope to answer my own question over three action packed days here at London’s Business Design Centre.
To quote a passing remark at the conference over the water machine “regen med- well it is in the rock and roll years”. It’s a time when the sector is gaining momentum and support, like those early years when rock and roll disrupted the sensibilities of the generations preceding it. The scepticism and outrage once displayed by popular media has been replaced by a quiet optimism and interest in what it could actually offer to the worried well to the desperately ill.
As an industry it is no longer finding its feet, largely placed within academia but rather the technology has spun out, grown and become reasonably established. Nervous investors are gaining confidence, as evidence by the first Investor Forum, here this year. Clinical trials are delivering results and platform technologies are evolving to support an industry needing the attention to standards for the medicinal products in a way not known before. As reflected in the programme, the need to share best practice and to work collaboratively is more than ever. So where are those gaps where new innovation is so needed and can we find them over three intense days, gathering a global community together?
This is the first installment in a series of blog posts by Dr Beverley Vaughan, Stevenage Bioscience Catalyst from this year’s World Stem Cells & Regenerative Medicine Congress, and its co-located Cord Blood World Europe, that took place 20-22 May 2015.